Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal MiceMichela Lisjak, Andrés F. Muro, Thibaut Marais et al.|Frontiers in Genome Editing|2022Cited by 23